People Who Are Overweight Or Obese In Middle Age May Be Less Likely To Develop Dementia Than Normal Weight, Underweight Peers.

HealthDay (4/10, Reinberg) reports that a study published online April 10 in The Lancet Diabetes & Endocrinology suggests that people “who are overweight or obese in middle age may be less likely to develop dementia than their normal and underweight peers.” The study, which included almost two million people, revealed that “overweight and obese people were [...]

Posted in Alzheimer’s, blog | Leave a comment

Report: Some Alzheimer’s Patients Not Told By Medical Professionals Of Their Diagnosis

The Wall Street Journal (3/24, D2, Beck, Subscription Publication) reports that the Alzheimer’s Association says that about 55 percent of people with Alzheimer’s and those who look after them may never have learned from their physician that they have the disease. The Washington Post (3/24, Kunkle) reports that in its annual report, the association found that “medical professionals are [...]

Posted in Alzheimer’s, blog | Leave a comment

Long-Term Study Of Medicine To Prevent Alzheimer’s Raises Questions

The Arizona Republic (2/23, Alltucker) reports in a 3,900-word article in a series focusing on Colombians with an inherited form of early onset Alzheimer’s caused by the paisa mutation that if crenezumab, the medication being used in a long-term study, is successful in preventing Alzheimer’s in this population, “the question becomes how would it attack the more [...]

Posted in Alzheimer’s, blog | Leave a comment

Alzheimer’s Researchers Focus On Paisa Mutation Carriers.

In a 3,800-word article, the Arizona Republic (2/15, Alltucker) reported that scientists are studying families in the Medellin and District of Antioquia areas of Colombia who suffer from early onset Alzheimer’s. Almost 20 years ago, researchers “traced the cause to a single genetic mutation passed from generation to generation.” That mutation is known as the paisa mutation. [...]

Posted in Alzheimer’s, blog | Leave a comment

High Dose and Extended Use of Anticholinergic Drugs May Increase Risk for Dementia, Study Suggests

Previous studies have suggested that medicines—both prescription and over-the-counter—aiming to block the actions of acetylcholine may be associated with increased risk for cognitive impairment, but a new studypublished this week in JAMA Internal Medicine shows that use of such medicines in older adults may increase risk for dementia. Researchers from the Geriatric Pharmacy Program at the University of [...]

Posted in Alzheimer’s, blog | Leave a comment

Amyloid and Anxiety May Speed Cognitive Decline in Preclinical Alzheimer’s, Study Suggests

High levels of anxiety concurrent with elevated amyloid beta (Aβ) levels in the brain were significantly associated with cognitive decline in healthy older adults, according to a report in JAMA Psychiatry. The results suggest that the combination could be crucial during the long preclinical phase of Alzheimer’s disease (AD). AD is known to have a preclinical phase in [...]

Posted in Alzheimer’s, blog | Leave a comment

Researchers To Begin Trials Of Potential Alzheimer’s Treatment

The Boston Herald (1/14, Kalter) reports that researchers at Boston University “are testing a pill,” called T-817MA, “that could protect the brain against the ravages of Alzheimer’s disease.” Dr. Robert Stern, Boston University’s principal investigator for the trial, said, “The goal of this new medication going into clinical trials is really to try and slow down the [...]

Posted in Alzheimer’s, blog | Leave a comment

People Turn To Unique Prevention Clinic To Fend Off Alzheimer’s

NBC Nightly News (12/16, story 7, 2:25, Williams) reported, “Cases of Alzheimer’s continue to grow in this country. More than five million Americans are living with it, and we’re told that number’s expected to triple by 2050.” The focus now turns to prevention because some “brain changes leading to Alzheimer’s can start as early as 20 [...]

Posted in Alzheimer’s, blog | Leave a comment

Alzheimer’s Medicine Shows Early Positive Results

The Wall Street Journal (12/3, Whalen, Subscription Publication) reports that Biogen Idec Inc. has announced positive interim results from an early-stage study of its medication, BIIB037, to treat Alzheimer’s. The results showed that after 54 weeks of treatment, the treatment had reduced beta amyloid levels in the brain and improved cognition when compared with the placebo among [...]

Posted in Alzheimer’s, blog | Leave a comment

Study: More Than Half Of Americans With Dementia Have Never Undergone Thinking, Memory Screening

HealthDay (11/27, Preidt) reported that research published online (12/1) in Neurology suggests that “more than half of Americans with dementia have never undergone screening of their thinking and memory skills.” The research “included almost 300 people with dementia, aged 70 and older, who were taking part in the national Health and Retirement Study.” The Medscape (12/1) reported that investigators “found [...]

Posted in Alzheimer’s, blog | Leave a comment